In conclusion, our study reported a comprehensive bioinformatics analysis of DEGs between HPV+/- HNSCC, which identified several p53 target genes that may have the potential to serve as reliable molecular biomarkers for the diagnosis and/or prognosis of HPV-associated HNSCC. This evidence concerns the gene TP53 and head and neck squamous cell carcinoma.